Berberine Inhibits Growth of Liver Cancer Cells by Suppressing Glutamine Uptake

References

• Grandhi MS, Kim AK, Ronnekleiv-Kelly SM, et al. Hepatocellular carcinoma: from diagnosis to treatment. Surg Oncol. 2016;25:74–85. doi:10.1016/j.suronc.2016.03.00227312032
   PubMed Web of Science ®Google Scholar
• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391:1301–1314. doi:10.1016/S0140-6736(18)30010-229307467
   PubMed Web of Science ®Google Scholar
• Couri T, Pillai A. Goals and targets for personalized therapy for HCC. Hepatol Int. 2019;13:125–137. doi:10.1007/s12072-018-9919-130600478
   PubMed Web of Science ®Google Scholar
• Eggert T, Greten TF. Current standard and future perspectives in non-surgical therapy for hepatocellular carcinoma. Digestion. 2017;96:1–4. doi:10.1159/00046428228605745
   PubMed Web of Science ®Google Scholar
• Boroughs LK, DeBerardinis RJ. Metabolic pathways promoting cancer cell survival and growth. Nat Cell Biol. 2015;17:351–359. doi:10.1038/ncb312425774832
   PubMed Web of Science ®Google Scholar
• Zhang J, Pavlova NN, Thompson CB. Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine. EMBO J. 2017;36:1302–1315. doi:10.15252/embj.20169615128420743
   PubMed Web of Science ®Google Scholar
• Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013;12:931–947. doi:10.1038/nrd400224287781
   PubMed Web of Science ®Google Scholar
• Bhutia YD, Ganapathy V. Glutamine transporters in mammalian cells and their functions in physiology and cancer. Biochim Biophys Acta. 2016;1863:2531–2539. doi:10.1016/j.bbamcr.2015.12.01726724577
   PubMed Web of Science ®Google Scholar
• Scalise M, Pochini L, Console L, et al. The human SLC1A5 (ASCT2) amino acid transporter: from function to structure and role in cell biology. Front Cell Dev Biol. 2018;6:96. doi:10.3389/fcell.2018.0009630234109
   PubMed Web of Science ®Google Scholar
• Garaeva AA, Oostergetel GT, Gati C, et al. Cryo-EM structure of the human neutral amino acid transporter ASCT2. Nat Struct Mol Biol. 2018;25:515–521. doi:10.1038/s41594-018-0076-y29872227
   PubMed Web of Science ®Google Scholar
• McCracken AN, Edinger AL. Nutrient transporters: the Achilles’ heel of anabolism. Trends Endocrinol Metab. 2013;24:200–208. doi:10.1016/j.tem.2013.01.00223402769
   PubMed Web of Science ®Google Scholar
• Wang K, Feng X, Chai L, et al. The metabolism of berberine and its contribution to the pharmacological effects. Drug Metab Rev. 2017;49:139–157. doi:10.1080/03602532.2017.130654428290706
   PubMed Web of Science ®Google Scholar
• Wu YY, Li TM, Zang LQ, et al. Effects of berberine on tumor growth and intestinal permeability in HCT116 tumor-bearing mice using polyamines as targets. Biomed Pharmacother. 2018;107:1447–1453. doi:10.1016/j.biopha.2018.08.13030257361
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang S. Berberine suppresses growth and metastasis of endometrial cancer cells via miR-101/COX-2. Biomed Pharmacother. 2018;103:1287–1293. doi:10.1016/j.biopha.2018.04.16129864910
   PubMed Web of Science ®Google Scholar
• Lin YS, Chiu YC, Tsai YH, et al. Different mechanisms involved in the berberine-induced antiproliferation effects in triple-negative breast cancer cell lines. J Cell Biochem. 2019;120:13531–13544. doi:10.1002/jcb.2862830957305
   PubMed Web of Science ®Google Scholar
• Liu P, Ge M, Hu J, et al. A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis. Hepatology. 2017;66:167–181. doi:10.1002/hep.v66.128370287
   PubMed Web of Science ®Google Scholar
• Mayers JR, Vander Heiden MG. Famine versus feast: understanding the metabolism of tumors in vivo. Trends Biochem Sci. 2015;40:130–140. doi:10.1016/j.tibs.2015.01.00425639751
   PubMed Web of Science ®Google Scholar
• Moreadith RW, Lehninger AL. The pathways of glutamate and glutamine oxidation by tumor cell mitochondria. Role of mitochondrial NAD(P)+-dependent malic enzyme. J Biol Chem. 1984;259:6215–6221.6144677
   PubMed Web of Science ®Google Scholar
• Hamanaka RB, Chandel NS. Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends Biochem Sci. 2010;35:505–513. doi:10.1016/j.tibs.2010.04.00220430626
   PubMed Web of Science ®Google Scholar
• Weinberg F, Hamanaka R, Wheaton WW, et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci U S A. 2010;107:8788–8793. doi:10.1073/pnas.100342810720421486
   PubMed Web of Science ®Google Scholar
• Welbourne TC. Ammonia production and glutamine incorporation into glutathione in the functioning rat kidney. Can J Biochem. 1979;57:233–237. doi:10.1139/o79-029436006
   PubMedGoogle Scholar
• Hosios AM, Hecht VC, Danai LV, et al. Amino acids rather than glucose account for the majority of cell mass in proliferating mammalian cells. Dev Cell. 2016;36:540–549. doi:10.1016/j.devcel.2016.02.01226954548
   PubMed Web of Science ®Google Scholar
• Alberghina L, Gaglio D. Redox control of glutamine utilization in cancer. Cell Death Dis. 2014;5:e1561. doi:10.1038/cddis.2014.51325476909
   PubMed Web of Science ®Google Scholar
• Wise DR, Thompson CB. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci. 2010;35:427–433. doi:10.1016/j.tibs.2010.05.00320570523
   PubMed Web of Science ®Google Scholar
• Earhart RH, Koeller JM, Davis HL. Phase I trial of 6-diazo-5-oxo-L-norleucine (DON) administered by 5-day courses. Cancer Treat Rep. 1982;66:1215–1217.7083223
   PubMedGoogle Scholar
• Wang Q, Beaumont KA, Otte NJ, et al. Targeting glutamine transport to suppress melanoma cell growth. Int J Cancer. 2014;135:1060–1071. doi:10.1002/ijc.v135.524531984
   PubMed Web of Science ®Google Scholar
• Jacque N, Ronchetti AM, Larrue C, et al. Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition. Blood. 2015;126:1346–1356. doi:10.1182/blood-2015-01-62187026186940
   PubMed Web of Science ®Google Scholar
• Zhao X, Petrashen AP, Sanders JA, et al. SLC1A5 glutamine transporter is a target of MYC and mediates reduced mTORC1 signaling and increased fatty acid oxidation in long-lived Myc hypomorphic mice. Aging Cell. 2019;18:e12947. doi:10.1111/acel.1294730909319
   PubMed Web of Science ®Google Scholar
• Osanai-Sasakawa A, Hosomi K, Sumitomo Y, et al. An anti-ASCT2 monoclonal antibody suppresses gastric cancer growth by inducing oxidative stress and antibody dependent cellular toxicity in preclinical models. Am J Cancer Res. 2018;8:1499–1513.30210919
   PubMed Web of Science ®Google Scholar
• Amelio I, Cutruzzola F, Antonov A, et al. Serine and glycine metabolism in cancer. Trends Biochem Sci. 2014;39:191–198. doi:10.1016/j.tibs.2014.02.00424657017
   PubMed Web of Science ®Google Scholar
• Kress TR, Sabo A, Amati B. MYC: connecting selective transcriptional control to global RNA production. Nat Rev Cancer. 2015;15:593–607. doi:10.1038/nrc398426383138
   PubMed Web of Science ®Google Scholar
• Dejure FR, Eilers M. MYC and tumor metabolism: chicken and egg. EMBO J. 2017;36:3409–3420. doi:10.15252/embj.20179643829127156
   PubMed Web of Science ®Google Scholar
• Wise DR, DeBerardinis RJ, Mancuso A, et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci U S A. 2008;105:18782–18787. doi:10.1073/pnas.081019910519033189
   PubMed Web of Science ®Google Scholar
• Zhang R, Qiao H, Chen S, et al. Berberine reverses lapatinib resistance of HER2-positive breast cancer cells by increasing the level of ROS. Cancer Biol Ther. 2016;17:925–934. doi:10.1080/15384047.2016.121072827416292
   PubMed Web of Science ®Google Scholar
• Liu B, Wang G, Yang J, et al. Berberine inhibits human hepatoma cell invasion without cytotoxicity in healthy hepatocytes. PLoS One. 2011;6:e21416. doi:10.1371/journal.pone.002141621738655
   PubMed Web of Science ®Google Scholar
• Ye M, Fu S, Pi R, et al. Neuropharmacological and pharmacokinetic properties of berberine: a review of recent research. J Pharm Pharmacol. 2009;61:831–837. doi:10.1211/jpp.61.07.000119589224
   PubMed Web of Science ®Google Scholar
• Farooqi AA, Qureshi MZ, Khalid S, et al. Regulation of cell signaling pathways by berberine in different cancers: searching for missing pieces of an incomplete jig-saw puzzle for an effective cancer therapy. Cancers (Basel). 2019;11:478. doi:10.3390/cancers11040478
   PubMed Web of Science ®Google Scholar